Ildong enters imaging market with Meditec purchase
This article was originally published in Clinica
Executive Summary
South Korean pharmaceutical company Ildong Pharm plans to enter the diagnostic equipment business with the purchase of a 51% stake in Meditec. Ildong aims to boost the diagnostic imaging company into the top five in South Korea by acquiring advanced technology from Japan and other countries, reports Pharma Koreana. It also intends to construct and operate a high-tech hospital.